Shreekant Parasuraman

2PUBLICATIONS
5CO-AUTHORS
Regenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 09, 2023
Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs.

Aaron T Gerds, Jingbo Yu, Anne Shah

|Mar 08, 2023
Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.

Shreekant Parasuraman, Ellen Thiel, Julie Park

Pageof 1